Connect with us

Wellness

Highlights from the journal CHEST®, January 2023

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical…

Published

on

This article was originally published by BioEngineering

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

Do Inhaled Corticosteroids Reduce All-Cause Mortality Risk in Patients With COPD?

Credit: Hong Chen, MD, et al. CHEST January 2023

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The January issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Starting in late 2022, readers have been earning continuing medical education (CME) credit for reading select journal CHEST articles and completing a posttest through the CHEST education portal,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “The articles eligible for CME in January are, ‘Association of Inhaled Corticosteroids With All-Cause Mortality Risk inPatients With COPD,’ which is highlighted below, and ‘Long-term Azithromycin in Children With Bronchiectasis Unrelated toCystic Fibrosis.’”

Also included in the current issue of the journal CHEST:

  • COPD
    A meta-analysis of 60 randomized clinical trials, “Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD,” demonstrated a reduced all-cause mortality risk in patients treated with inhaled corticosteroids as part of their therapy regimen. A visual abstract for the research can be viewed here.
  • Critical Care
    “Temporal Trends and Variation in Bronchoscopy Use for Acute RespiratoryFailure in the United States” finds that the variable use of bronchoscopy among mechanically ventilated patients with respiratory failure suggests potentially unwarranted practice variation and need for further studies to clarify which patients may benefit from bronchoscopy. A visual abstract for the research can be viewed here.
  • Thoracic Oncology
    A research letter, “A Biomarker-Based Approach for the Determination of Sample Adequacy During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration,” finds that a multivariate biomarker approach accurately reflects endobronchial ultrasound-guided transbronchial needle aspiration samples arising from predominantly lymphoid tissue and is suitable for subsequent diagnostic testing. A podcast of experts discussing the research can be found here.
  • Pulmonary Vascular
    Original research, “Sex Differences in Outcomes of Percutaneous Pulmonary ArteryThrombectomy in Patients With Pulmonary Embolism,” finds that women had higher rates of in-hospital mortality, procedural bleeding, increased quantities of blood product transfusions and increased vascular complications. An editorial related to the research can be found here.

To view the entire January issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.



Wellness

Lion’s Mane Mushroom: History, Benefits, and Adaptogen Properties

Explore the intriguing world of Lion’s Mane Mushroom in our comprehensive guide. Dive into its unique properties, historical significance, and myriad health…

Continue Reading
Wellness

AI can already diagnose depression better than a doctor and tell you which treatment is best

Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…

Continue Reading
Wellness

Reasons You should Get this: Neptune Wellness Solutions Inc (NASDAQ:NEPT), WeTrade Group Inc. (NASDAQ:WETG)

NEPT has seen its SMA50 which is now -9.28%. In looking the SMA 200 we see that the stock has seen a -92.25%. WETG has seen its SMA50 which is …
The…

Continue Reading

Trending